Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?

Puja M. Shah, Brandy L. Edwards, Zachary C. Dietch, Christopher A. Guidry, Stephen W. Davies, Sara A. Hennessy, Therese M. Duane, Patrick J. O'Neill, Raul Coimbra, Charles H. Cook, Reza Askari, Kimberly Popovsky, Robert G. Sawyer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Numerous studies have demonstrated microorganism interaction through signaling molecules, some of which are recognized by other bacterial species. This interspecies synergy can prove detrimental to the human host in polymicrobial infections. We hypothesized that polymicrobial intra-abdominal infections (IAI) have worse outcomes than monomicrobial infections. Methods: Data from the Study to Optimize Peritoneal Infection Therapy (STOP-IT), a prospective, multicenter, randomized controlled trial, were reviewed for all occurrences of IAI having culture results available. Patients in STOP-IT had been randomized to receive four days of antibiotics vs. antibiotics until two days after clinical symptom resolution. Patients with polymicrobial and monomicrobial infections were compared by univariable analysis using the Wilcoxon rank sum, χ2, and Fisher exact tests. Results: Culture results were available for 336 of 518 patients (65%). The durations of antibiotic therapy in polymicrobial (n = 225) and monomicrobial IAI (n = 111) were equal (p = 0.78). Univariable analysis demonstrated similar demographics in the two populations. The 37 patients (11%) with inflammatory bowel disease were more likely to have polymicrobial IAI (p = 0.05). Polymicrobial infections were not associated with a higher risk of surgical site infection, recurrent IAI, or death. Conclusion: Contrary to our hypothesis, polymicrobial IAI do not have worse outcomes than monomicrobial infections. These results suggest polymicrobial IAI can be treated the same as monomicrobial IAI.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalSurgical Infections
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Intraabdominal Infections
Coinfection
Anti-Bacterial Agents
Infection
Surgical Wound Infection
Therapeutics
Randomized Controlled Trials
Demography

ASJC Scopus subject areas

  • Surgery
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections? / Shah, Puja M.; Edwards, Brandy L.; Dietch, Zachary C.; Guidry, Christopher A.; Davies, Stephen W.; Hennessy, Sara A.; Duane, Therese M.; O'Neill, Patrick J.; Coimbra, Raul; Cook, Charles H.; Askari, Reza; Popovsky, Kimberly; Sawyer, Robert G.

In: Surgical Infections, Vol. 17, No. 1, 01.01.2016, p. 27-31.

Research output: Contribution to journalArticle

Shah, PM, Edwards, BL, Dietch, ZC, Guidry, CA, Davies, SW, Hennessy, SA, Duane, TM, O'Neill, PJ, Coimbra, R, Cook, CH, Askari, R, Popovsky, K & Sawyer, RG 2016, 'Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?', Surgical Infections, vol. 17, no. 1, pp. 27-31. https://doi.org/10.1089/sur.2015.127
Shah, Puja M. ; Edwards, Brandy L. ; Dietch, Zachary C. ; Guidry, Christopher A. ; Davies, Stephen W. ; Hennessy, Sara A. ; Duane, Therese M. ; O'Neill, Patrick J. ; Coimbra, Raul ; Cook, Charles H. ; Askari, Reza ; Popovsky, Kimberly ; Sawyer, Robert G. / Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?. In: Surgical Infections. 2016 ; Vol. 17, No. 1. pp. 27-31.
@article{2f11f59c9b634f2fa81ae7ce8f111cd8,
title = "Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?",
abstract = "Background: Numerous studies have demonstrated microorganism interaction through signaling molecules, some of which are recognized by other bacterial species. This interspecies synergy can prove detrimental to the human host in polymicrobial infections. We hypothesized that polymicrobial intra-abdominal infections (IAI) have worse outcomes than monomicrobial infections. Methods: Data from the Study to Optimize Peritoneal Infection Therapy (STOP-IT), a prospective, multicenter, randomized controlled trial, were reviewed for all occurrences of IAI having culture results available. Patients in STOP-IT had been randomized to receive four days of antibiotics vs. antibiotics until two days after clinical symptom resolution. Patients with polymicrobial and monomicrobial infections were compared by univariable analysis using the Wilcoxon rank sum, χ2, and Fisher exact tests. Results: Culture results were available for 336 of 518 patients (65{\%}). The durations of antibiotic therapy in polymicrobial (n = 225) and monomicrobial IAI (n = 111) were equal (p = 0.78). Univariable analysis demonstrated similar demographics in the two populations. The 37 patients (11{\%}) with inflammatory bowel disease were more likely to have polymicrobial IAI (p = 0.05). Polymicrobial infections were not associated with a higher risk of surgical site infection, recurrent IAI, or death. Conclusion: Contrary to our hypothesis, polymicrobial IAI do not have worse outcomes than monomicrobial infections. These results suggest polymicrobial IAI can be treated the same as monomicrobial IAI.",
author = "Shah, {Puja M.} and Edwards, {Brandy L.} and Dietch, {Zachary C.} and Guidry, {Christopher A.} and Davies, {Stephen W.} and Hennessy, {Sara A.} and Duane, {Therese M.} and O'Neill, {Patrick J.} and Raul Coimbra and Cook, {Charles H.} and Reza Askari and Kimberly Popovsky and Sawyer, {Robert G.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1089/sur.2015.127",
language = "English (US)",
volume = "17",
pages = "27--31",
journal = "Surgical Infections",
issn = "1096-2964",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Do Polymicrobial Intra-Abdominal Infections Have Worse Outcomes than Monomicrobial Intra-Abdominal Infections?

AU - Shah, Puja M.

AU - Edwards, Brandy L.

AU - Dietch, Zachary C.

AU - Guidry, Christopher A.

AU - Davies, Stephen W.

AU - Hennessy, Sara A.

AU - Duane, Therese M.

AU - O'Neill, Patrick J.

AU - Coimbra, Raul

AU - Cook, Charles H.

AU - Askari, Reza

AU - Popovsky, Kimberly

AU - Sawyer, Robert G.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: Numerous studies have demonstrated microorganism interaction through signaling molecules, some of which are recognized by other bacterial species. This interspecies synergy can prove detrimental to the human host in polymicrobial infections. We hypothesized that polymicrobial intra-abdominal infections (IAI) have worse outcomes than monomicrobial infections. Methods: Data from the Study to Optimize Peritoneal Infection Therapy (STOP-IT), a prospective, multicenter, randomized controlled trial, were reviewed for all occurrences of IAI having culture results available. Patients in STOP-IT had been randomized to receive four days of antibiotics vs. antibiotics until two days after clinical symptom resolution. Patients with polymicrobial and monomicrobial infections were compared by univariable analysis using the Wilcoxon rank sum, χ2, and Fisher exact tests. Results: Culture results were available for 336 of 518 patients (65%). The durations of antibiotic therapy in polymicrobial (n = 225) and monomicrobial IAI (n = 111) were equal (p = 0.78). Univariable analysis demonstrated similar demographics in the two populations. The 37 patients (11%) with inflammatory bowel disease were more likely to have polymicrobial IAI (p = 0.05). Polymicrobial infections were not associated with a higher risk of surgical site infection, recurrent IAI, or death. Conclusion: Contrary to our hypothesis, polymicrobial IAI do not have worse outcomes than monomicrobial infections. These results suggest polymicrobial IAI can be treated the same as monomicrobial IAI.

AB - Background: Numerous studies have demonstrated microorganism interaction through signaling molecules, some of which are recognized by other bacterial species. This interspecies synergy can prove detrimental to the human host in polymicrobial infections. We hypothesized that polymicrobial intra-abdominal infections (IAI) have worse outcomes than monomicrobial infections. Methods: Data from the Study to Optimize Peritoneal Infection Therapy (STOP-IT), a prospective, multicenter, randomized controlled trial, were reviewed for all occurrences of IAI having culture results available. Patients in STOP-IT had been randomized to receive four days of antibiotics vs. antibiotics until two days after clinical symptom resolution. Patients with polymicrobial and monomicrobial infections were compared by univariable analysis using the Wilcoxon rank sum, χ2, and Fisher exact tests. Results: Culture results were available for 336 of 518 patients (65%). The durations of antibiotic therapy in polymicrobial (n = 225) and monomicrobial IAI (n = 111) were equal (p = 0.78). Univariable analysis demonstrated similar demographics in the two populations. The 37 patients (11%) with inflammatory bowel disease were more likely to have polymicrobial IAI (p = 0.05). Polymicrobial infections were not associated with a higher risk of surgical site infection, recurrent IAI, or death. Conclusion: Contrary to our hypothesis, polymicrobial IAI do not have worse outcomes than monomicrobial infections. These results suggest polymicrobial IAI can be treated the same as monomicrobial IAI.

UR - http://www.scopus.com/inward/record.url?scp=84955325075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955325075&partnerID=8YFLogxK

U2 - 10.1089/sur.2015.127

DO - 10.1089/sur.2015.127

M3 - Article

C2 - 26397376

AN - SCOPUS:84955325075

VL - 17

SP - 27

EP - 31

JO - Surgical Infections

JF - Surgical Infections

SN - 1096-2964

IS - 1

ER -